The cancer threat is a devastating life-changer. In India, the rising number of cancer patients and those dying of the ...

Media Release Marking Immutep's transition to a Phase III biotech, the Company's pivotal TACTI-004 trial in first-line non-small cell lung cancer (1L NSCLC) received first regulatory approvalMature da ...

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

Scientists say identification of two epigenetically different states in mouse model opens door to "entirely new world of ...

Building on clinical data from millions of individuals who received lipid-encapsulated mRNA vaccines, the FDA has issued new guidance that could facilitate a faster transition to first-in-human trials ...

NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platformFindings in lung cancer show that CTCs can provide additional biomarkers not found in ctDNA from single b ...

Subgroup analyses showed that patients treated with platinum-based agents and taxanes had the highest prevalence of chronic ...

A revolutionary personalized cancer vaccine developed by Russia’s Gamaleya Research Institute of Epidemiology and ...

Distinct epigenetic patterns established during early development influence an individual’s risk of developing cancer later ...